[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"nb-uvb\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:nb-uvb":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":4},"100588797","immunomodulatory-effects-of-nb-uvb-and-steroids-in-vitiligo-a-study-on-cxcl11-and-temra-biomarkers-100588797",false,"NCT06946069","Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers","Expression of CXCL11 & TEMRA in Serum of Vitiligo Patients Treated With Narrow-band UVB","Inclusion Criteria:\n\nClinically diagnosed non-segmental vitiligo (stable for ≥3 months).\n\nFitzpatrick skin types III-V (common in the Egyptian population).\n\nNo recent systemic therapy for vitiligo (within the last 3 months).\n\nExclusion Criteria:\n\nPhotosensitivity disorders (e.g., lupus, porphyria).\n\nPregnancy or breastfeeding.\n\nActive infections, malignancies, or immunosuppressive conditions.\n\nHistory of hypertrophic scarring or melanoma.","ALL",{"count":18,"type":19},40,"ESTIMATED","INTERVENTIONAL",[22],"NA","this is a prospective, randomized controlled trial (RCT) investigating the immunological effects of narrowband UVB (NB-UVB) phototherapy-both as monotherapy and in combination with oral mini-pulse (OMP) steroids-in non-segmental vitiligo patients. The study evaluates changes in CXCL11 (a chemokine involved in T-cell recruitment) and TEMRA (terminally differentiated effector memory T cells re-expressing CD45RA) levels in serum before and after treatment.",[25,26],"Vitiligo","NB-UVB",[28,26,29,30],"vitiligo","CXCL11","TEMRA","NOT_YET_RECRUITING","2025-04-19",{"date":34,"type":35},"2025-04-27","ACTUAL",{"date":37,"type":19},"2025-09-01",{"date":39,"type":19},"2026-09-30",{"name":41,"class":42},"Assiut University","OTHER"]